GINCELERATOR 3.0 Accelerator Program — Frequently Asked Questions
Answers to the questions founders most often ask about GINCELERATOR 3.0 Accelerator Program — who qualifies, the funding amount, required documents and how the application works.
Frequently asked questions
What is the total funding amount offered?
The program offers up to ₹10L in grant funding, along with prize money and other non-financial benefits.
What is the application deadline?
The deadline for applications is January 16, 2026.
Who is eligible to apply?
DPIIT-registered startups working in healthtech or medtech domains with solutions at TRL levels 5 to 8, and at post-MVP or early revenue stage are eligible.
Which sectors are covered?
Eligible focus areas include AI and IoMT-based diagnostics, remote monitoring, oncology, neurology, cardiology, infectious diseases, radiology, hospital automation, AI-based clinical decision support, and digital health platforms.
Does the program take equity?
The program provides grant funding, which is non-dilutive and does not require equity.
Is DPIIT registration required?
Yes, startups must be DPIIT-registered to apply.
What are the key benefits besides funding?
Selected startups get access to hospitals and clinical experts, mentorship from industry and medical leaders, investor readiness support, infrastructure support, workshops, and prize money.
How long is the accelerator program?
It is a structured 6-month accelerator journey.
How do I apply?
Applications are accepted online via the GINSERV community portal at the provided apply URL.
What documents are typically needed?
The provided facts do not list specific documents, but DPIIT registration and details on TRL level, solution validation, and revenue stage are likely required.
Who offers GINCELERATOR 3.0 Accelerator Program?
GINCELERATOR 3.0 Accelerator Program is offered by GINSERV, an academic institution. It is provided as non-dilutive funding.